Acetyl-CoA carboxylase beta, encoded by the ACAB gene, plays an important role in the oxidation of fatty acids. The aim of this study was to check the hypothesis that allelic variants of ACACB influence the risk of obesity and type 2 diabetes mellitus.
INTRODUCTION
Obesity and type 2 diabetes mellitus are two prevalent disorders in western countries, with a well known relationship between them [1] . Obesity constitutes a major risk factor for the development of diabetes and it is always associated with insulin resistance [2] . As many common disorders, diabetes and obesity have an important genetic component. Genome-wide studies have identified several loci related to these disorders [3] [4] [5] [6] [7] , but those loci only explain a small fraction of the disease risk, and in many cases do not identify the causal variants [8;9] , suggesting that most of the genes involved and the functional variants remain to be identified in further investigations.
It is well recognized that changes in fatty acid metabolism, particularly fatty acid oxidation, play an important role in the development of insulin resistance. Skeletal muscle from obese people is less able to oxidize fat [10] , which is exacerbated in the skeletal muscle of patients with type 2 diabetes [11;12] . The metabolism of insulin-resistant skeletal muscle appears to favor fat synthesis rather than fat oxidation [13] . The imbalance between fatty acid synthesis and fatty acid oxidation further increases lipid accumulation within the cytoplasm of skeletal muscle cells, which would turn these cells even more resistant to insulin.
Acetyl-CoA carboxylase (ACAC) catalyzes the synthesis of malonyl-CoA, a key molecule in fatty acid metabolism. In humans, there are two ACAC isoforms, ACACA and ACACB, encoded by genes located in chromosomes 17 and 12, respectively. Whereas ACACA is predominantly expressed in the liver and adipose tissue, the heart and skeletal muscle are the major tissues expressing ACACB. It has been suggested that ACACA plays a major role in fatty acid synthesis, whereas ACACB is preferentially involved in fatty acid oxidation [14;15] . Thus, ACACB is an appealing candidate gene for obesity and diabetes, which are characterized by an impaired fat oxidation.
Therefore, the aim of this study was to test the hypothesis that allelic variants of the ACACB gene are associated with obesity and/or diabetes.
MATERIALS AND METHODS

Study subjects and genotyping
The discovery cohort included 972 Caucasian postmenopausal women from the general population (mean age 66; range 47-88) taking part in epidemiologic studies about mineral metabolism and cardiovascular risk [16;17] . All were living in Cantabria, a small region in Northern Spain and provided informed consent. Women with non-Spanish ancestors were excluded. We selected tagging SNPs covering the common variation of the ACACB gene with Tagger software using the following parameters: minor allele frequency (MAF) of 10%, capture threshold of r 2 >= 0.8, and a maximum tagging distance of 200 kb. For comparison purposes, the rs1121980 polymorphism of the FTO gene was also studied, as it has been associated with obesity in several studies [18] . DNA was isolated from peripheral blood by using standard procedures and quantified with the Qubit system (Invitrogen). SNPs were analysed by iPlex technology on a Mass-Array platform (Sequenom, Germany).
SNPs showing phenotypic associations in the discovery cohorts were also analyzed in the Valencia 
RESULTS
Association of ACACB polymorphisms with adiposity
The characteristics of women studied are shown in table 1.
One of the 26 SNPs selected was excluded because of genotyping technical problems (rs4766587); 3
other SNPs were excluded because questionable HWE, with uncorrected p-values <0.05 (table 2) .
The haplotypic block structure is shown in figure 1 .
The single locus analysis did not reveal significant associations of ACACB polymorphisms with BMI in the general population. Likewise, no association was found between the FTO polymorphism and BMI. However, in the whole study group (general population and women with severe obesity together), rs2268388 genotypes were significantly associated with BMI (p=0.0043), almost reaching the 0.0037 threshold for significance after correction for multiple tests. T alleles were associated with higher BMI. The mean BMI values in women with TT, TC and CC genotypes were 34.1±8.4, 32.0±11.9 and 30.4±7.2 kg/m 2 , respectively. The haplotypic analysis confirmed the results but did not increase the strength of association (not shown), and the haplotypic conditional analysis revealed that rs2268388 was the only independent contributor to the association. There were marked differences between the genotype frequencies in the general population and in women with severe obesity: T alleles were overrepresented in the severe obesity population (18%, versus 10% in 
. Similar results were found in the haplotypic analysis (not shown).
In the Valencia cohort, the rs2268388 was not associated with BMI, thus confirming the lack of association between BMI and ACACB allelic variants in the general population.
Association of ACACB polymorphisms with type 2 diabetes
Since obesity is a well-known factor associated with type 2 diabetes, we analyzed the association of ACACB polymorphisms with diabetes mellitus after excluding women with marked elevations of BMI (ie, BMI>35).
We found several polymorphisms within a 14 kb distance of rs2268388 associated with diabetes (table 4) . The rs2239607 polymorphism, located 3.5 kb downstream of rs2268388, showed the strongest association, almost reaching the multiple test-adjusted significance. C alleles were associated with higher risk of diabetes. The genotypes frequencies were: CC 7.9%, CT 42.1% and TT 50.0% in diabetic patients; and 3.6%, 32.1% and 64.3%, respectively, in non-diabetic women.
Similar results were obtained when BMI was included as a covariate (table 4) .
Two polymorphisms associated with type 2 diabetes in the discovery cohort were also analyzed in the Valencia cohort, rs2268388 and rs2239607. In this cohort both polymorphisms also showed a significant association with type 2 diabetes, that appeared to fit better a recessive genetic model (pvalues 0.005 and 0.021, respectively). The risk alleles were the same in both populations (Cantabria and Valencia): T alleles at the rs2268388 locus and C alleles at rs2239607 locus. Thus, when the results of both cohorts were combined, in comparison with the most common CC genotype at rs2268388, OR for the TT genotype was 3.6, whereas in comparison with the most common TT genotype at the rs2239607 locus, OR for CC genotype was and 2.8 (95% CI 1.4-5.6) (table 5).
Functional analysis of rs2268388 and rs2239607
The ability of different alleles to bind transcription factors was explored by EMSA. The experiments showed that the T-allele oligonucleotide of rs2268388 had higher binding than the C-allele, a result confirmed in competition experiments (figure 3). Similar EMSA experiments were carried out with oligonucleotides specific for the two alleles of the rs2239607 polymorphism. As shown in the figure   3 , there were allelic differences in nuclear protein binding, with stronger binding to the T-allele oligonucleotides.
The in silico analysis of transcription factor binding sites suggested that the nucleotide change 
DISCUSSION
ACACB encodes one of the major forms of the enzyme catalyzing the synthesis of malonyl-CoA.
Malonyl-CoA serves both as an intermediate in fatty acid synthesis and as an allosteric inhibitor of carnitine palmitoyltranferase 1(CPT1) which regulates the transfer of long-chain fatty acyl-CoAs from the cytosol into the mitochondria. The two isoforms of ACAC, ACACA and ACACB, have a high degree of sequence identity, the major difference being in the N-terminal domain of ACACB, which is known to help the binding to the mitochondrial membrane and regulates local malonyl-CoA levels, CPT1 activity and consequently fatty acid oxidation [10] . The different ability of ACACA and ACACB to bind to the mitochondrial membrane, together with their tissue expression patterns, suggest that the fate of the malonyl-CoA synthesized is different: while ACACA is preferentially involved in fatty acids synthesis, ACACB controls fatty acid oxidation. In agreement with this, ACACA knock out mice, with a markedly impaired ability to synthesize fatty acids, die before birth.
The effect of ACACB suppression in mice is controversial. Initial reports suggested that null mice are leaner than wild type, mainly due to an increased rate of fat oxidation in both heart and skeletal We found that T alleles at the rs2268388 locus were much more frequent in women with severe obesity than in controls. Interestingly enough, the strength of association was similar to that of FTO, a well-recognized candidate gene for obesity [ 18;33-35 ]. However, we did not find a statistically significant association of ACACB alleles with BMI in the general population. These results suggest that ACACB variants have a stronger influence on extreme BMI than on the variation of BMI within the normal or moderately increased range. The explanation for this observation is unclear, but it is tempting to speculate that diet and other acquired factors may play a predominant role in overweight and mild obesity, whereas genetic factors may be the most important in severe obesity. On the other hand, these results reflect the "power of extremes", this is, the interest of studying extreme phenotypes when exploring the involvement of genes in common disorders [ 36 ] .
ACACB polymorphisms were also associated with type 2 diabetes mellitus. In this analysis we excluded women with severe obesity, who have a very high frequency of diabetes. The results were replicated in two independent cohorts and confirmed the association of ACACB variants with disorders of energy metabolism. The association of ACACB with diabetes is not surprising as an association of this gene with the metabolic syndrome has been reported recently [ 37 ] . The results presented here indicate that there is an imperfect overlapping of the SNPs associated with severe obesity and those associated with diabetes. This is an intriguing result because the major SNPs associated with either condition are only 3.0 kb apart. It is possible to speculate that changes in the polymorphic loci studied, or in the surrounding regions, produce subtle functional changes that in turn modify ACACB activity. Since SNPs associated with obesity or diabetes are located in introns, the most plausible explanation is that their alleles influence ACACB gene expression. Both obesity and diabetes are disorders with a large environmental influence. Therefore, the lack of complete overlapping between the loci associated with obesity and diabetes might reflect the existence of regulatory elements responding to different environmental factors and causing subtle changes in gene expression. Interestingly, the reported association of ACACB with the metabolic syndrome seems to be modulated by dietary fat [ 37 ] .
Our study has some limitations. We only studied Caucasian women. Therefore, it is unclear if these results can be extrapolated to men or women with other ethnic background. On the other hand, we
have limited information about dietary habits and physical activity. Therefore, we could not explore the potential interactions between those acquired factors and genetic factors, which clearly is an important subject for future studies. Candidate gene studies can have false positive results, due to population stratification and other causes of bias. We used various strategies to diminish this risk and support the validity of the associations. First, we studied women from a limited geographic area and excluded those with non-Spanish ancestors. Second, we used a multiple test-corrected threshold for statistical significance to diminish the type I error risk related to the multiple SNPs analyzed.
Furthermore, we replicated the association of ACACB polymorphisms with type 2 diabetes in a different cohort of women. Unfortunately, a group of women with severe obesity was not available for replication. On the other hand, the association between ACACB polymorphisms, obesity and diabetes is plausible from a biological point of view, as discussed above. In multivariate analyses the association between ACACB polymorphisms and type 2 diabetes was independent of BMI.
However, there were very few patients with diabetes and BMI<25. Therefore, we could not make a BMI-stratified analysis to compare the strength of association between ACACB variants and diabetes in overweight and lean women.
We also explored the potential functional consequences of the allelic changes in vitro. Although the study of the regulatory properties of the regions surrounding SNPs is a complex issue, we used an indirect approach by analyzing the changes in the protein binding properties of those DNA regions.
Our in vitro studies demonstrated a differential binding of nuclear factors to the alleles of the major loci associated with obesity and diabetes. These results are in line with those by Maeda et al [ 31 ] and suggested a functional role of those polymorphisms. However, as an alternative explanation, the association between ACACB variants and obesity/diabetes could be actually due to other true regulatory loci in linkage disequilibrium with those analyzed in the present study. Whether the polymorphisms are located in real regulatory elements or not will require further research.
Nevertheless, bioinformatics analyses and EMSA with competing oligonucleotides suggested that the glucocorticoid receptor and SRF bound to the polymorphic regions of the ACACB gene. These results are quite interesting, in view of the well-recognized metabolic effects of glucocorticoids, and the recently reported influence of SRF on insulin resistance [ 38 ] .
In summary, our results show that allelic variants of the ACACB gene are associated with severe obesity and with type 2 diabetes mellitus, thus adding new information to the complex genetic nature of those disorders. Further studies are required to elucidate the molecular mechanisms involved and to delineate the interactions between environmental factors and gene variants.
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TABLES
The association of the FTO polymorphism is also shown for comparison. The retarded band is pointed with an arrow.
